Quick Answer
JOHNSON & JOHNSON reported Total Revenue of $94.19 billion for fiscal year 2025.
JOHNSON & JOHNSON — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $94.19B +6.0% |
$88.82B +4.3% |
$85.16B +6.5% |
$79.99B +1.6% |
$78.74B -4.7% |
$82.58B +0.6% |
| Revenue (ASC 606) | $94.19B +6.0% |
$88.82B +4.3% |
$85.16B +6.5% |
$79.99B +1.6% |
$78.74B -4.7% |
$82.58B +0.6% |
| Net Income | $26.80B +90.6% |
$14.07B -60.0% |
$35.15B +95.9% |
$17.94B -14.1% |
$20.88B +41.9% |
$14.71B -2.7% |
| Diluted EPS | $11.03 +90.5% |
$5.79 -57.8% |
$13.72 +103.9% |
$6.73 -13.8% |
$7.81 +41.7% |
$5.51 -2.1% |
| Total Assets | $199.21B +10.6% |
$180.10B +7.5% |
$167.56B -10.6% |
$187.38B +2.9% |
$182.02B +4.1% |
$174.89B +10.9% |
| Cash and Equivalents | $19.71B -18.2% |
$24.11B +10.3% |
$21.86B +69.6% |
$12.89B -11.0% |
$14.49B +3.6% |
$13.98B -19.2% |
| Long-Term Debt | $39.44B +28.7% |
$30.65B +18.4% |
$25.88B -3.7% |
$26.89B -10.3% |
$29.98B -8.1% |
$32.63B +23.2% |
| Stockholders Equity | $81.54B +14.1% |
$71.49B +3.9% |
$68.77B -10.5% |
$76.80B +3.8% |
$74.02B +17.0% |
$63.28B +6.4% |
| R&D Expense | $109.00M -94.1% |
$1.84B +281.2% |
$483.00M | $0.00 | $0.00 | — |
| Gross Profit | $63.94B +4.2% |
$61.35B +4.7% |
$58.61B +5.8% |
$55.39B +0.1% |
$55.34B +2.2% |
$54.16B -0.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $23.99B | +6.8% | +1.1% |
| Revenue (ASC 606) | September 30, 2025 | $23.99B | +6.8% | +1.1% |
| Net Income | September 30, 2025 | $5.15B | +91.2% | -7.0% |
| Diluted EPS | September 30, 2025 | $2.12 | +91.0% | -7.4% |
| Total Assets | September 30, 2025 | $192.82B | +8.1% | -0.3% |
| Cash and Equivalents | September 30, 2025 | $18.23B | -8.8% | -1.9% |
| Long-Term Debt | September 30, 2025 | $39.41B | +25.9% | +0.4% |
| Stockholders Equity | September 30, 2025 | $79.28B | +13.0% | +1.0% |
| Gross Profit | September 30, 2025 | $16.69B | +7.6% | +3.6% |
- JOHNSON & JOHNSON reported Total Revenue of $94.19 billion for fiscal year 2025.
- JOHNSON & JOHNSON showed an increase of +6.0% in Total Revenue compared to the prior fiscal year.
- JOHNSON & JOHNSON reported Revenue (ASC 606) of $94.19 billion for fiscal year 2025.
- JOHNSON & JOHNSON showed an increase of +6.0% in Revenue (ASC 606) compared to the prior fiscal year.
- JOHNSON & JOHNSON reported Net Income of $26.80 billion for fiscal year 2025.
- JOHNSON & JOHNSON showed an increase of +90.6% in Net Income compared to the prior fiscal year.
- JOHNSON & JOHNSON reported Diluted EPS of $11.03 per share for fiscal year 2025.
- JOHNSON & JOHNSON showed an increase of +90.5% in Diluted EPS compared to the prior fiscal year.
- JOHNSON & JOHNSON reported Total Assets of $199.21 billion for fiscal year 2025.
- JOHNSON & JOHNSON showed an increase of +10.6% in Total Assets compared to the prior fiscal year.
- JOHNSON & JOHNSON reported Cash and Equivalents of $19.71 billion for fiscal year 2025.
- JOHNSON & JOHNSON showed a decrease of -18.2% in Cash and Equivalents compared to the prior fiscal year.
- JOHNSON & JOHNSON reported Long-Term Debt of $39.44 billion for fiscal year 2025.
- JOHNSON & JOHNSON showed an increase of +28.7% in Long-Term Debt compared to the prior fiscal year.
- JOHNSON & JOHNSON reported Stockholders Equity of $81.54 billion for fiscal year 2025.
- JOHNSON & JOHNSON showed an increase of +14.1% in Stockholders Equity compared to the prior fiscal year.
- JOHNSON & JOHNSON reported R&D Expense of $109.00 million for fiscal year 2025.
- JOHNSON & JOHNSON showed a decrease of -94.1% in R&D Expense compared to the prior fiscal year.
- JOHNSON & JOHNSON reported Gross Profit of $63.94 billion for fiscal year 2025.
- JOHNSON & JOHNSON showed an increase of +4.2% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: